Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $20.80 Consensus Price Target from ...

Retrieved on: 2024-06-09 12:25:55

Tags for this article:

LX2020

Click the tags to see associated articles and topics

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $20.80 Consensus Price Target from .... View article details on hiswai:

Excerpt

... gene therapy candidate for the treatment of hypertrophic cardiomyopathy, or HCM caused by TNNI3 gene. See Also. Five stocks we like better than ...

Article found on: www.defenseworld.net

View Original Article